Summary
Overview
Work History
Education
Skills
Accomplishments
Timeline
Generic

KENJI ARAKI

TOCHIGI/ NOGI-town Marubayashi 370-33

Summary

Scientist for new modality discovery. I have been working on gene therapy for cancers and drug delivery systems of nucleotide medicine. QUALIFICATIONS -9 years’ experience in immunology -9 years’ experience in gene therapy.

Overview

18
18
years of professional experience

Work History

Principal Scientist

Tokiwa Bio inc.
03.2023 - Current
  • Supervises research and driving the AMED program
  • Establishment of stealth RNA vector (SRV) manufacturing process and transfer to CDMO

Vice Senior Scientist

KYORIN Pharmaceutical Co., Ltd
04.2005 - 03.2023
  • I have been engaged in research work in pharmacology and CMC (Chemistry, Manufacturing and Control) mainly in the field of gene therapy
  • In addition to conducting the aforementioned studies, I have also gained experience in preparing study protocols, investigational new drug summaries, and responding to inquiries as a study contractor and study director, and have achieved results with the gene therapy drug Ad-REIC
  • I am particularly strong in the field of gene therapy and has received external evaluations of my research results through publications and JST's technical evaluation meetings
  • In the Ad-REIC project, I was engaged as a project leader of a joint research team.

Education

bachelor's degree - Applied Biological Chemistry

Osaka Prefecture University

Master of Science - Biology

Osaka University

Ph.D. -

Tsukuba University
03.2024

Skills

  • FPLC (virus purification)
  • Molecular biology
  • Biochemistry
  • Animal experiments
  • Immunological Techniques

Accomplishments

  • “Development of a quantitative methylation-specific droplet digital PCR assay for detecting Dickkopf-related protein 3.” Araki K, Kurosawa A, Kumon H. BMC Res Notes. 2022 May 13;15(1):169.
  • “REIC/Dkk-3 Gene Therapy Induces Immunogenic Cell Death in a Mouse Model of MalignantMesothelioma.” Araki K, Yamamuro N, Tomonobu N, Kumon H. Anticancer Res. 2021 Oct;41(10):4837-4855. (Issue Highlights)

Timeline

Principal Scientist

Tokiwa Bio inc.
03.2023 - Current

Vice Senior Scientist

KYORIN Pharmaceutical Co., Ltd
04.2005 - 03.2023

bachelor's degree - Applied Biological Chemistry

Osaka Prefecture University

Master of Science - Biology

Osaka University

Ph.D. -

Tsukuba University
KENJI ARAKI